IL15 and neoplasm: demonstrated that oncolytic adenovirus encoding IL‐15 (Ad‐IL15) activated the STING‐TBK1‐IRF3 pathway in DCs, thereby promoting TLS formation and inhibiting tumor growth in a mouse model.